Exobiosphere, the world’s first contract research organization dedicated to drug discovery in space, has raised €2 million in a seed round to scale its orbital high-throughput screening platform.

Exobiosphere Secures LuxIMPULSE Contract to Advance Space-Based Drug Discovery